Author:
Maleki Farzaneh,Gaitonde Puneet,Miller Shannon,Trame Mirjam N.,Coen Paul M.,Garhyan Parag,Schmidt Stephan
Publisher
Springer International Publishing
Reference85 articles.
1. Alvarez CA, Lingvay I, Vuylsteke V, Koffarnus RL, McGuire DK. Cardiovascular risk in diabetes mellitus: complication of the disease or of antihyperglycemic medications. Clin Pharmacol Ther. 2015;98(2):145–61.
2. Cusi K. Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions. Diabetologia. 2016;59(6):1112–20.
3. Lonardo A, Sookoian S, Pirola CJ, Targher G. Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metab Clin Exp. 2016;65(8):1136–50.
4. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–603.
5. Association AH, Association AS. Cardiovascular disease: a costly burden for America. Projections through 2035. Washington, DC: American Heart Association; 2017.